Usage and awareness of antiviral medications for COVID-19
View ORCID ProfileN Kojima, JD Klausner
doi: https://doi.org/10.1101/2022.04.21.22274155
N Kojima
1Department of Medicine, University of California Los Angeles, Los Angeles, 90095
JD Klausner
2Department of Population and Public Health Sciences, University of Southern California, Keck School of Medicine, Los Angeles, 90033
![Loading Loading](https://www.medrxiv.org/sites/all/modules/contrib/panels_ajax_tab/images/loading.gif)
Data Availability
All data produced in the present study are available upon reasonable request to the authors.
Posted April 26, 2022.
Usage and awareness of antiviral medications for COVID-19
N Kojima, JD Klausner
medRxiv 2022.04.21.22274155; doi: https://doi.org/10.1101/2022.04.21.22274155
Subject Area
Subject Areas
- Addiction Medicine (337)
- Allergy and Immunology (664)
- Anesthesia (179)
- Cardiovascular Medicine (2607)
- Dermatology (220)
- Emergency Medicine (392)
- Epidemiology (12150)
- Forensic Medicine (10)
- Gastroenterology (752)
- Genetic and Genomic Medicine (4038)
- Geriatric Medicine (381)
- Health Economics (672)
- Health Informatics (2609)
- Health Policy (995)
- Hematology (359)
- HIV/AIDS (834)
- Medical Education (397)
- Medical Ethics (109)
- Nephrology (429)
- Neurology (3810)
- Nursing (208)
- Nutrition (567)
- Oncology (1996)
- Ophthalmology (580)
- Orthopedics (235)
- Otolaryngology (303)
- Pain Medicine (250)
- Palliative Medicine (73)
- Pathology (470)
- Pediatrics (1102)
- Primary Care Research (443)
- Public and Global Health (6478)
- Radiology and Imaging (1380)
- Respiratory Medicine (867)
- Rheumatology (396)
- Sports Medicine (337)
- Surgery (439)
- Toxicology (52)
- Transplantation (185)
- Urology (165)